{"ticker": {"uuid": "11ece199-d4bb-4648-a8f7-8eef3fd9e478", "symbol": "COR", "name": "Cencora Inc.", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Distribution"}, "articles": [{"title": "Cencora Inc. stock underperforms Wednesday when compared to competitors", "summary": "Cencora Inc. (COR) stock fell 1.89% to $296.57 on Wednesday, underperforming the broader market which saw the S&P 500 and Dow Jones Industrial Average rise. This marks the second consecutive day of losses for the company's stock.", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-underperforms-wednesday-when-compared-to-competitors-08893702-952584ef199f?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-15T20:47:32", "published_display": "15 Jul 2026 20:47", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Cencora\u2019s Revenue Miss Amid Growth Will Impact Cencora (COR) Investors", "summary": "Cencora (COR) reported past-quarter revenues of US$78.36 billion, a 3.8% year-on-year increase, but missed analyst expectations by 3.9%. This revenue miss, despite overall growth, raises questions about the company's ability to maintain its valuation amidst margin pressures and e", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/how-cencoras-revenue-miss-amid-growth-will-impact-cencora-co/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-15T19:07:47", "published_display": "15 Jul 2026 19:07", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC4571978 Bond Coupon Profile \u2014 Rate & Payments", "summary": "This article provides a coupon profile for the Cencora, Inc. bond ABC4571978, detailing its interest rate and payment schedule. The bond has a current coupon rate of 4.30%, with the next payment planned for December 15, 2026. It offers additional details on past and upcoming payo", "url": "https://www.tradingview.com/symbols/FINRA-ABC4571978/profile-coupon/", "source_name": "TradingView", "published_at": "2026-07-15T19:07:41", "published_display": "15 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABGB Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the ABGB bond, issued by Cencora, Inc. The bond is a 3.45% security maturing on December 15, 2027, with an outstanding amount of $750 million. Cencora, Inc. is a pharmaceutical sourcing and distribution company, operating through U.S. and Int", "url": "https://www.tradingview.com/symbols/DUS-ABGB/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-15T12:08:35", "published_display": "15 Jul 2026 12:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC6310085 Bond Coupon Profile \u2014 Rate & Payments", "summary": "This article provides a coupon profile for the ABC6310085 bond issued by Cencora, Inc. The bond has a coupon rate of 5.65% with the next payment scheduled for August 13, 2026. It highlights the availability of detailed coupon data including rates and payment schedules for investo", "url": "https://www.tradingview.com/symbols/FINRA-ABC6310085/profile-coupon/", "source_name": "TradingView", "published_at": "2026-07-15T11:37:49", "published_display": "15 Jul 2026 11:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock reflects steady growth as healthcare distribution evolves", "summary": "Cencora Inc. (ISIN US15135B1017) is a major US healthcare services company, providing pharmaceutical distribution and logistics. The company's stock reflects its crucial role in the supply chain, facilitating the movement of drugs from manufacturers to healthcare providers and of", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-reflects-steady-growth-as-healthcare-distribution-evolves/69769439", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-14T23:19:35", "published_display": "14 Jul 2026 23:19", "sentiment": "positive", "sentiment_pct": 82, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US3073EAT2 Bond Risk Profile", "summary": "This page provides an overview of the US3073EAT2 bond issued by Cencora, Inc., maturing on March 15, 2031, with a 2.7% coupon rate. It focuses on the bond's risk profile, offering key metrics for credit risk assessment such as security level, inflation protection, and issuer rati", "url": "https://www.tradingview.com/symbols/FWB-US3073EAT2/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T21:38:27", "published_display": "14 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. stock underperforms Tuesday when compared to competitors", "summary": "Cencora Inc. (COR) shares dropped 1.26% on Tuesday, closing at $302.28, despite a positive trading day for the broader market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains. This decline broke Cencora's two-day winning streak.", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-underperforms-tuesday-when-compared-to-competitors-7f8e0794-dd29422259d2", "source_name": "MarketWatch", "published_at": "2026-07-14T16:47:00", "published_display": "14 Jul 2026 16:47", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC4987224 Bond Risk Profile", "summary": "This page provides a risk profile for the ABC4987224 bond issued by Cencora, Inc., maturing on May 15, 2030, with a 2.8% coupon. It offers an overview of the bond's features, credit risk assessment metrics like security level and issuer rating, and access to analyst ratings. The ", "url": "https://www.tradingview.com/symbols/FINRA-ABC4987224/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T15:37:31", "published_display": "14 Jul 2026 15:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Following Soft Earnings Is The Stock Starting To Look Undervalued", "summary": "Cencora (COR) reported quarterly revenue of $78.36 billion, up 3.8% year-on-year but below consensus forecasts. Despite recent share price gains, the stock is down 9.66% year to date but has a 5-year total shareholder return of 186.24%. The company is considered 12.7% undervalued", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-following-soft-earnings-is-the-stock-starting-to", "source_name": "Simply Wall Street", "published_at": "2026-07-14T15:32:50", "published_display": "14 Jul 2026 15:32", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora : World Courier Expands Cold Chain Capabilities | Cencora", "summary": "Cencora's World Courier has expanded its cold chain capabilities. This news is distributed via Public Technologies and focuses on the company's efforts to enhance its pharmaceutical distribution services, particularly for temperature-sensitive products. The article mentions Cenco", "url": "https://www.marketscreener.com/news/cencora-world-courier-expands-cold-chain-capabilities-cencora-ce7f5edcd080f020", "source_name": "www.marketscreener.com", "published_at": "2026-07-14T12:53:50", "published_display": "14 Jul 2026 12:53", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock reflects steady growth in pharmaceutical distribution and services", "summary": "Cencora Inc. (ISIN US15135B1017) is a key player in the US pharmaceutical distribution and healthcare services sector, with its stock performance linked to growth in drug spending, specialty therapies, and supply-chain efficiency. The company's strategy emphasizes scale, data-dri", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-reflects-steady-growth-in-pharmaceutical-distribution-and/69762588", "source_name": "Ad Hoc News", "published_at": "2026-07-14T00:45:28", "published_display": "14 Jul 2026 00:45", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC4987224 Bond Profile \u2014 Key Metrics", "summary": "This article provides key financial metrics for the ABC4987224 bond issued by Cencora, Inc. The bond has a 2.8% coupon rate and matures on May 15, 2030, with an outstanding amount of $500 million. Cencora, Inc. is a pharmaceutical sourcing and distribution services company operat", "url": "https://www.tradingview.com/symbols/FINRA-ABC4987224/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-13T23:37:31", "published_display": "13 Jul 2026 23:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPcFpBclIwNjhnZDBoTm5aWWp0dlY0UE1fVndranFyM1pLUHdOMFo3TWNBa1ZIMDd4TXpydGpxSTBLY3VQcHBjbnE5M2k3bk5ySE4tbFhjbkpCV0NlVE05d1ZSQ3BMMmtCZTJ6TWI5R0VEcWN1UXhWV2UwUnl5R2YtdmNMa1ozUmlyYm5yV3pkbUtRb1lLcEJLOURwM3lzUQ?oc=5", "source_name": "Market source", "published_at": "2026-07-13T21:58:39+00:00", "published_display": "13 Jul 2026 21:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock reflects steady healthcare distribution role in a complex market", "summary": "Cencora Inc. plays a crucial role in the U.S. pharmaceutical supply chain as a large-scale distributor and services provider. The company's business model relies on high revenue volumes with thin margins, driven by efficient logistics, strong customer relationships, and expansion", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-reflects-steady-healthcare-distribution-role-in-a-complex/69759760", "source_name": "Ad Hoc News", "published_at": "2026-07-13T10:37:28", "published_display": "13 Jul 2026 10:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Stock Still Looks Undervalued On Cash Flow And Earnings", "summary": "Cencora (COR) stock appears undervalued based on its discounted cash flow (DCF) intrinsic value estimate and P/E ratio comparison. The DCF model suggests a 39.6% discount, while the P/E of 23.2x is below the healthcare sector average and a tailored benchmark. Investors should con", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-stock-still-looks-undervalued-on-cash-flow-and-e/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-12T22:37:20", "published_display": "12 Jul 2026 22:37", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Cencora, Inc. Stocks", "summary": "This article provides a list of Exchange Traded Funds (ETFs) that hold shares of Cencora, Inc. The ETFs are sorted by their market value and include details such as weight in the fund, issuer, management style, expense ratio, assets under management (AUM), price, change percentag", "url": "https://www.tradingview.com/symbols/MIL-1COR/etfs/", "source_name": "TradingView", "published_at": "2026-07-10T19:07:29", "published_display": "10 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock trades steadily as healthcare distribution scale supports long-term growth", "summary": "Cencora Inc. plays a crucial role as a major U.S. healthcare distributor, focusing on pharmaceutical distribution, logistics, and related services, which are critical for connecting manufacturers, pharmacies, and healthcare providers. The company's stable demand in the healthcare", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-trades-steadily-as-healthcare-distribution-scale-supports/69735878", "source_name": "Ad Hoc News", "published_at": "2026-07-10T07:32:00", "published_display": "10 Jul 2026 07:32", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. stock underperforms Thursday when compared to competitors", "summary": "Cencora Inc. (COR) shares dropped 2.30% to $302.46 on Thursday, despite a strong day for the broader stock market, which saw the S&P 500 Index and Dow Jones Industrial Average rise. This decline ended a six-day winning streak for the stock.", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-underperforms-thursday-when-compared-to-competitors-18244a68-7ade887d0eb8", "source_name": "MarketWatch", "published_at": "2026-07-09T20:46:00", "published_display": "09 Jul 2026 20:46", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardinal's Growth Momentum Looks Strong From Prescription Trends, Specialty Investments, and GLP-1s", "summary": "Cardinal Health, a major player in pharmaceutical distribution, is experiencing strong growth. This momentum is attributed to favorable prescription trends, strategic investments in specialty pharmaceuticals, and the rising impact of GLP-1 drugs. The company, alongside Cencora an", "url": "https://www.morningstar.com/company-reports/1487460-cardinals-growth-momentum-looks-strong-from-prescription-trends-specialty-investments-and-glp-1s", "source_name": "Morningstar", "published_at": "2026-07-09T20:08:36", "published_display": "09 Jul 2026 20:08", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pricing Headwinds and Industry Trends Cut Into Cencora's 2026 Sales, but Fundamentals Remain Strong", "summary": "Cencora, a key player in the pharmaceutical wholesale and distribution market, is facing pricing headwinds and industry trends that are projected to impact its 2026 sales figures. Despite a recent guidance cut and stock selloff, the company's fundamental business strategy and out", "url": "https://www.morningstar.com/company-reports/1487467-pricing-headwinds-and-industry-trends-cut-into-cencoras-2026-sales-but-fundamentals-remain-strong", "source_name": "Morningstar", "published_at": "2026-07-09T20:08:09", "published_display": "09 Jul 2026 20:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "McKesson's Oncology Leadership and Robust Free Cash Flow Underpin Strong Durable Fundamentals", "summary": "McKesson, a major pharmaceutical wholesaler, benefits from its leadership in oncology and strong free cash flow, contributing to its durable fundamentals. The company, along with Cardinal Health and Cencora, forms an oligopoly that distributes over 90% of the U.S. pharmaceutical ", "url": "https://www.morningstar.com/company-reports/1487466-mckessons-oncology-leadership-and-robust-free-cash-flow-underpin-strong-durable-fundamentals", "source_name": "Morningstar", "published_at": "2026-07-09T19:42:31", "published_display": "09 Jul 2026 19:42", "sentiment": "positive", "sentiment_pct": 67, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (NYSE:COR) Stock Forecast & Analyst Predictions", "summary": "Cencora (NYSE:COR) is projected to grow earnings by 5.9% and revenue by 5.6% annually, with EPS expected to increase by 9.2% per annum and a forecast return on equity of 53.8% in three years. Recent updates include increased EPS estimates for fiscal year 2026, though revenue outl", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/future", "source_name": "Simply Wall Street", "published_at": "2026-07-09T07:07:27", "published_display": "09 Jul 2026 07:07", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. stock outperforms competitors on strong trading day", "summary": "Shares of Cencora Inc. (COR) rose 1.67% to $309.57 on Wednesday, marking its sixth consecutive day of gains. This performance occurred on a dismal trading day for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both declining. Cencora's stock consequen", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-outperforms-competitors-on-strong-trading-day-6f237afe-487d67085cdf?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-08T16:45:00", "published_display": "08 Jul 2026 16:45", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. focuses on pharmaceutical distribution scale as investors eye healthcare demand", "summary": "Cencora Inc. is a major U.S. pharmaceutical distributor, with its business model tied to prescription demand and healthcare utilization. The company specializes in distributing pharmaceuticals and offers supporting services, with a growing focus on specialty pharmaceuticals. Inve", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-inc-focuses-on-pharmaceutical-distribution-scale-as-investors-eye/69720643", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T06:56:00", "published_display": "08 Jul 2026 06:56", "sentiment": "positive", "sentiment_pct": 70, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Adjusts Price Target on Cencora to $330 From $300", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-adjusts-price-target-131756525.html", "source_name": "MT Newswires", "published_at": "2026-07-07T13:17:56+00:00", "published_display": "07 Jul 2026 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. highlights its role in pharmaceutical distribution. Investors watch the company\u2019s evo", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPRXhzYUNmYWhtRjlDNmp5RHMyWnNyRFpaUkozZEQ0UVVaN1AtM1FUdWswYlIxN1J2Z0pQV1RHS1dTNGlyYnVVVk1aTFFhOWM3LWx4SUs5Z2JXSzEzV00tUGRVN3J4UVBQSFhFbWpla3pxTmthM3FIdHozb3hhSWMycl9FUFlRVnRrd1Y4UnJsZFBsMFBfaDF6Sk9hcDVxUUtXQndBOUc3RDJzUWpZbGxSeUU3MUx2MWJwTDA3aDV2bTEtWnhKbzRVVUF0Yw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-06T09:28:02+00:00", "published_display": "06 Jul 2026 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. focuses on healthcare distribution scale as investors assess long-term growth prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPbDZFSkkwY2tUNjFiSWNIdThZRUdWamhBMG8wNXFtUXVXck5HcHVNcTkwZE1jUXdMNVFDS2ZuQVZyY05LeGs3TVlHaGQ0SzVOVWwtd01FaDhGWU1nM0tmMmg2THlIQ2RqUkVwWFY2dlVqOVBCd01qWHhhMmlXYVVXYWlPNExkcW1SajM0V0ZCUUQyVkdhS3dEeEdpaHBENXRiQXVOZVpUeUM5dEdVRWhVZjJLc3BQNUNJUGJRc3ktVGJlY0ltRkNyaHJOQQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-03T13:17:43+00:00", "published_display": "03 Jul 2026 13:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cencora-announces-date-time-third-203000029.html", "source_name": "Business Wire", "published_at": "2026-07-01T20:30:00+00:00", "published_display": "01 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora lines up Aug. 5 earnings call before NYSE opens", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPY2xlRlVmRDMxbFZ2cXNUb2xkWndQcEJiRjJFSC1XQkkxRVJscmxvN0FBNFhqUDFrd2IwVHFFX0hyZi1PUzVCY19PcjRuclF6TE9IMlJESWNXdzNwYTZ2UW9telZvazc0RkxNRFVGeUs2U2lHME5TTVNNTll1NDVSM1luaDBMZEhJV2lfbi1qLUhRVDhRUkxWaDZfNW1ORTBWYmhNYnlKODFhTm1qOThYSkF2akdxUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cencora-pick-week-smart-insider-134146124.html", "source_name": "MT Newswires", "published_at": "2026-06-30T13:41:46+00:00", "published_display": "30 Jun 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora reports steady business model, shares anchored in US healthcare distribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONFg0Tm1WdnZncTI3SXp4ckFkUVk3NkVwNVNDWHRjandXQUp5VUJIZHN1WnFLM0xRZ1ozeXpEcWRQRWR1RE9PZHIzMWlJQ0hqOVltWDRXUlZhVUtBYmRCQVQ4Qk5WcHNTM2xrS0d4YmlyZy1TdHRCTVh4WmoxdVYzNnhzZDBYNXZIemxmZ0lOQ0d5MzItQUpaRmVBVUE4YUNuVTF3Tnh2OXYtWFVzTnJLem5Mb1RpMHlBREMtQUlGLXFyT3VGWFBreg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-30T10:13:12+00:00", "published_display": "30 Jun 2026 10:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNenppZ3JZbDRIVUw3Ukl4dVg2bE91WGh5WkxjYkRNNW9vNWdfZ01TMlJsdHhWRUNyU0E1NjAyUXRBcGM0TWZib2dKOFQ1NEY1Y29zUFc0ZlYydTNoeVRVVXpIc0RWbDJzSkJYRzNuS3FlazJJeEx1M29kT1JXb2w1d19Wbkt4TnVCNlBkNmpBVjNEeVZRQU5LUUdHQnR5SG8?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNbmVndmI3eTFsUDNHSjhGYTVSWG1hWDI4SE5EZUFnYXdMUVdsYmxUY01SRk5iX1IwQkF6WGFqOWVyV042OGNWczRrei1MUHc3cUxNSkZzaGVOQ3NtVXVpY2ZHdWRRLU9CZ05VQlFQaW5iNXhyZ3o3bzZaX3NlNTRoZlhwZEs3ZkwzTFp1ZjhMWEdDcFFsY3d4ZUdva0NPdHVV?oc=5", "source_name": "Market source", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) director adds 4,000 shares in open-market stock purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOb1pwaVVDUVJoSldvUnlIYWMxWXUxWTZwQkRldHA1Qkpqd01MWWtULWlIbmxjTFJrTzFCbVZTdzhjd1YzOE1jWDg0b1BGWjNqcGg0SzRXZlR0NWNocmVkUThuVThkQVAwMUE0cjBka2hTWGJqUWlCVHIyYTJVM3JPeWw2NDdjUlBvQ3ItUHQ0bzNYRmVId3BQNlJvc29DTFUxeTRRb2hvcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Stock - Saturday spotlight on the business model behind the drug distributor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOY1dpekNMTUJzRmlMOW1MSUFTcHRTYlJPVG5lb3A2OEpsOVVBT2ZFRldZTkhnZTU3U2pVVjA1V3BwYXIzdWlmaHdjX29pZzg3VXJZWG1nSGN6TjVUeENKUFpHeWE1dVV6TEpvVWJFd1pzWkJoSVJrbU15OUJkalgtcjRSdkdKNExUNE1tRE1tMHNTSVJ1aUxMNHJzd3ZxeFRNLTU2ZUxaQWJwWVBHVE53MlhWNDhSWHhrLTJfVjlLUjBySXhDUTVMYw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T08:32:54+00:00", "published_display": "20 Jun 2026 08:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. Stock (US15135B1017): Valuation metrics in focus after steady share price climb", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPa0RfOEJXbEw0UTh6SFRwdmloWmQzam5nTjRYVUJ6ODRweGhEU3FKdWhDNGplWG03dEp1Y0taNVRLOFkwSXJRZmFpN0JkVlh5YWJ6M0JTZWdrMzFISDFNVzZuOVhKTUlzRnBwREN4eU5nekJ2MTNtbXktREcyT2hVTEhRTlRXcmRDdU9yaVlWLUEtVHJLZWFfOWpNUHpLMTdLdHl1MDR5VjZfd0QwSlZmeWNxaWY3NEtBMW5lVkVZSFg3QUV6d1JwUA?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Cencora Stock Underperforming the Nasdaq?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOUkFZWlF6S2dzbS1EOVotci1TTHpTYzZWRWNCRHI0aGFSQl9jWnNCLWgyckMtV2dVd3pZajhWVThhOEdtODc4NkZ0RkJGWWRZUFBXdUU1ODk3S2NKLThOV2JLMjlEcTRuQkpRWGFySXpGbllFSXExQjBkaG5lei1yTlIxa2VlMGl5U2FwVjJmcXVzSlJNQ2t1LTlUV1luVE1xdk5J?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora-Kite Agreement Signals CGT Commercialization Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPMVMwcHc2RG44T1hXYVVCMVJZMFJBbndROXhNWjZ6SWlXSXQ2SW4zWUpjeEotRFZ3d1hPU1ZldlpDM0I4dkxySjJpeDQ4Q2xIUk41elpXUzhETjhvY085QTZxaElZazhrUXpVV0lpVXhTYlJkLVJSU2hpRDl0eG1TZ3l1S3ZhTURweFhpeVoxN0hnOTNNTWlTRkZVUjY?oc=5", "source_name": "Pharmaceutical Commerce", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Spends US$1.1m Buying More Shares In Cencora", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock (US15135B1017): transformation story after name change and solid earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxORHFwY0p6REdmazhaNjRkdmJDZGhfdlM0ZF9VdmpoQ01aUWFaSUlyYmdZNG8tSjJvVm83bFIyYXRGbFY2dVBWX1NOYVM5TmlwckZQVXRDN05VejJTX3lPZGtCMThqaDdjeVNGYk0xQmYzRjViQWpRcGhWaUREYzZQWG9ZQVhrNkxZOTdoQ3lMbVlXSlVfSXo5TzFVUHFqUkN2bWpJOHZLeEdhUEVGZjRQZzFwRTJRRXl1R2trdkR3TzVvWUtYYU5J?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wells Fargo Maintains Overweight Rating on Cencora (COR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNeVQydkZFUlNGd2ZEa1h2UkN0SEpjcUtmR0J6SkJZa3plS1hvaUs1cW1OVUdfdWVPQWtCYVlDeXFvMzZGSDF6ZEUzT3dIQkdvUmFJY1FPMjJRWkxyQXdKSFRWZGt0OF9pS3lQM0l5ZnVlaFpCOTh2THlQVmdrVzRZaTdaQUx1d0JyZkhYbm1DOFhCVFItRVBpYWJsZ3FHWHRheUVxUjRZMA?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (NYSE:COR) Could Be A Buy For Its Upcoming Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPVk9vclQ5VElSbkI4ZTJHbks2VzJaVXlmbS1XNWNkNE1TdVo1ZkRkaU5EcDMzQ3NiSWdPR3ZGV2dfazZFWXhaY1NMX2Y5bTlQMTc1bmV5aUVyVEFIWEJsOVcydno1bTdiMFRoWnU1Ti05eDN3WVNpZ2xuYktCc2hFRmVRLVJvT0VvZHNwRVdaTUxJaFFBOUh0WVFMMC1pSXZWS0Zta2pLbmhaRmljLTNycl95cV9QeEpnVkV3MF9Udk_SAcYBQVVfeXFMTkRWRTZTWm5fMFdETDNqU1ZxQzhKUWRURGlyRGgtS1lIQVVMZFRHeWZCbUlKN09JSmViNkR0YmVxUTFrZEJkcTZtS0wxaDdwM0N0YWxKM3R5OXFMc1JPd2tJMi0zd3c4UnpkNlhST0VQeHc1V2pmU2hTNkpsRUpqQjVfY2VfSERBNE5hWnhHWWxaWDNaRmg2cWRLbHhsbUItTElraVFfcUNJWmlfdDhIdHZkRlpPMDFiM3c1VVAxek02d2laQnl3?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Q2 2026 EPS Surge Tests Bullish Earnings Growth Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Misses Q2 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPYVppeHphSXQ4OWFObkhWNEdKOHFQUmRPRzhMZm0ySWFYQmYxYUhzSlNHdGZxdWtGcF9sS0xnUnYzNnZXejZOSVJ6QWpnMk4yRkN6LU5ZZUFnVXFlV3o1WjJDbkZ6QkJ5c2ZYeENKY0EtbUNYTUlqNTVPMFpYMm04b0h0ZmI1c2VKVExYU3NfU2s4MEktM0lxV1RFZw?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNNWJKODBSQmlMaGtXQVVBbnNxUzJldmEyWEdnblZtUWdxVkpuTGZ1ajd2Z2ZHWG9JTVZYYXVwTWJZb2tfcmtmRk0wS1hxSjBYNlJjQTZ6VkJuc01JUFVEOG0zYWNSbEJqZkk2VDJMa3h3WEhZbVQ2ZmtLQldYQjNCZTVZUm1IREQyOTRaWnhrM181Qkd6LUJqeGlR?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora will post quarterly results before the market opens May 6", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOSWRtUXZqaFFsYkI5YjdSYTh0bmVFeTRFTWx2OEpjbUNSaUNnVklrdF93WTV0YW5jd3NnSjRrTmRrUllyY0JSUDgxT0VzLTBfTXBTakphYkxCMVh6QkcxYmNmUTNYZlBPMW5RT2g1R1dFTFpveXRLZm9kNk1zbGt5OU9QemFjbWp0X1EyQkw3SFNlT29nYVlmVm5oMEs4NmhIekxMVVoyUmk5QzQ4Q3BBM1JCckdBaGM?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPNVpMa3RjQ2NZdmVFZGxMMTUyaXZsU09yVkFiYnhNenRRc0tnVnphRHd2bVlEVkFqeVBsT0FhX0dFSmR4M0xIUDR5X3FVMUpmQ283R04tLW01TVJLZzlLdm9UVXpPTlVrdUFQZTd3dTcyeTVwUno0MUxWb2FLNVMwdG1vNXVZRi1wR0VoLUNSYXVUNGhudW80QmttRDk1QQ?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora's $1.1B eye-care deal adds EyeSouth retina doctors", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOUDk4dmNRSXh0ajMxbU5CVXoxai01cC1vTUxha25yZEIyNzhGWGNETWp1QU9XZWwzMVdYWTlWdUZPMHlxYS1YcFNMMjRVc0JieWx3SWRCbUlLTmtQcHJSeGQ3MnRyR3RBeXJsNjJlZFJkN3pwdko4eWFyUjVjY0h3ejl3SU1oX2VGOEJXaXN3di1ManhtRjhxcDNPQi1VamZCR2o2YVU2VzFZVW1nbkpHaTJ0U0lJSmh1SVZTeWZn?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBKZ0JjM2d5Y09yMEFfdEs3U0lYRmtBMlJBTUxGWm5PMW5zOWhGbnVJR01XeWM5RS15QUhuSmY4dGQ3enF0UVBkajV2blJUY0Z0V21xM0J4Z2txM1Z1QnRGQ3Q1LUxRQWhIMUZudFlGZ3hQWXlMekxramVUQkZhb1k?oc=5", "source_name": "Market source", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. (COR) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE15anVpYURlbEVpSVhpX1JLSms5b0l1OGZQVEoxcXRtZ1pHY0ZqWkVXNk53YXN1eVk1UzNFallmMW1veEJtd1BtS1JzOFRrWlhlRUdBRTZR?oc=5", "source_name": "Gotrade", "published_at": "2026-02-02T14:40:24+00:00", "published_display": "02 Feb 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-09T07:00:00+00:00", "published_display": "09 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cencora Inc. stock underperforms Wednesday when compared to competitors", "summary": "Cencora Inc. (COR) stock fell 1.89% to $296.57 on Wednesday, underperforming the broader market which saw the S&P 500 and Dow Jones Industrial Average rise. This marks the second consecutive day of losses for the company's stock.", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-underperforms-wednesday-when-compared-to-competitors-08893702-952584ef199f?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-15T20:47:32", "published_display": "15 Jul 2026 20:47", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Cencora\u2019s Revenue Miss Amid Growth Will Impact Cencora (COR) Investors", "summary": "Cencora (COR) reported past-quarter revenues of US$78.36 billion, a 3.8% year-on-year increase, but missed analyst expectations by 3.9%. This revenue miss, despite overall growth, raises questions about the company's ability to maintain its valuation amidst margin pressures and e", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/how-cencoras-revenue-miss-amid-growth-will-impact-cencora-co/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-15T19:07:47", "published_display": "15 Jul 2026 19:07", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC4571978 Bond Coupon Profile \u2014 Rate & Payments", "summary": "This article provides a coupon profile for the Cencora, Inc. bond ABC4571978, detailing its interest rate and payment schedule. The bond has a current coupon rate of 4.30%, with the next payment planned for December 15, 2026. It offers additional details on past and upcoming payo", "url": "https://www.tradingview.com/symbols/FINRA-ABC4571978/profile-coupon/", "source_name": "TradingView", "published_at": "2026-07-15T19:07:41", "published_display": "15 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABGB Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the ABGB bond, issued by Cencora, Inc. The bond is a 3.45% security maturing on December 15, 2027, with an outstanding amount of $750 million. Cencora, Inc. is a pharmaceutical sourcing and distribution company, operating through U.S. and Int", "url": "https://www.tradingview.com/symbols/DUS-ABGB/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-15T12:08:35", "published_display": "15 Jul 2026 12:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC6310085 Bond Coupon Profile \u2014 Rate & Payments", "summary": "This article provides a coupon profile for the ABC6310085 bond issued by Cencora, Inc. The bond has a coupon rate of 5.65% with the next payment scheduled for August 13, 2026. It highlights the availability of detailed coupon data including rates and payment schedules for investo", "url": "https://www.tradingview.com/symbols/FINRA-ABC6310085/profile-coupon/", "source_name": "TradingView", "published_at": "2026-07-15T11:37:49", "published_display": "15 Jul 2026 11:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock reflects steady growth as healthcare distribution evolves", "summary": "Cencora Inc. (ISIN US15135B1017) is a major US healthcare services company, providing pharmaceutical distribution and logistics. The company's stock reflects its crucial role in the supply chain, facilitating the movement of drugs from manufacturers to healthcare providers and of", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-reflects-steady-growth-as-healthcare-distribution-evolves/69769439", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-14T23:19:35", "published_display": "14 Jul 2026 23:19", "sentiment": "positive", "sentiment_pct": 82, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US3073EAT2 Bond Risk Profile", "summary": "This page provides an overview of the US3073EAT2 bond issued by Cencora, Inc., maturing on March 15, 2031, with a 2.7% coupon rate. It focuses on the bond's risk profile, offering key metrics for credit risk assessment such as security level, inflation protection, and issuer rati", "url": "https://www.tradingview.com/symbols/FWB-US3073EAT2/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T21:38:27", "published_display": "14 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. stock underperforms Tuesday when compared to competitors", "summary": "Cencora Inc. (COR) shares dropped 1.26% on Tuesday, closing at $302.28, despite a positive trading day for the broader market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains. This decline broke Cencora's two-day winning streak.", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-underperforms-tuesday-when-compared-to-competitors-7f8e0794-dd29422259d2", "source_name": "MarketWatch", "published_at": "2026-07-14T16:47:00", "published_display": "14 Jul 2026 16:47", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC4987224 Bond Risk Profile", "summary": "This page provides a risk profile for the ABC4987224 bond issued by Cencora, Inc., maturing on May 15, 2030, with a 2.8% coupon. It offers an overview of the bond's features, credit risk assessment metrics like security level and issuer rating, and access to analyst ratings. The ", "url": "https://www.tradingview.com/symbols/FINRA-ABC4987224/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T15:37:31", "published_display": "14 Jul 2026 15:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Following Soft Earnings Is The Stock Starting To Look Undervalued", "summary": "Cencora (COR) reported quarterly revenue of $78.36 billion, up 3.8% year-on-year but below consensus forecasts. Despite recent share price gains, the stock is down 9.66% year to date but has a 5-year total shareholder return of 186.24%. The company is considered 12.7% undervalued", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-following-soft-earnings-is-the-stock-starting-to", "source_name": "Simply Wall Street", "published_at": "2026-07-14T15:32:50", "published_display": "14 Jul 2026 15:32", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora : World Courier Expands Cold Chain Capabilities | Cencora", "summary": "Cencora's World Courier has expanded its cold chain capabilities. This news is distributed via Public Technologies and focuses on the company's efforts to enhance its pharmaceutical distribution services, particularly for temperature-sensitive products. The article mentions Cenco", "url": "https://www.marketscreener.com/news/cencora-world-courier-expands-cold-chain-capabilities-cencora-ce7f5edcd080f020", "source_name": "www.marketscreener.com", "published_at": "2026-07-14T12:53:50", "published_display": "14 Jul 2026 12:53", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock reflects steady growth in pharmaceutical distribution and services", "summary": "Cencora Inc. (ISIN US15135B1017) is a key player in the US pharmaceutical distribution and healthcare services sector, with its stock performance linked to growth in drug spending, specialty therapies, and supply-chain efficiency. The company's strategy emphasizes scale, data-dri", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-reflects-steady-growth-in-pharmaceutical-distribution-and/69762588", "source_name": "Ad Hoc News", "published_at": "2026-07-14T00:45:28", "published_display": "14 Jul 2026 00:45", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABC4987224 Bond Profile \u2014 Key Metrics", "summary": "This article provides key financial metrics for the ABC4987224 bond issued by Cencora, Inc. The bond has a 2.8% coupon rate and matures on May 15, 2030, with an outstanding amount of $500 million. Cencora, Inc. is a pharmaceutical sourcing and distribution services company operat", "url": "https://www.tradingview.com/symbols/FINRA-ABC4987224/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-13T23:37:31", "published_display": "13 Jul 2026 23:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPcFpBclIwNjhnZDBoTm5aWWp0dlY0UE1fVndranFyM1pLUHdOMFo3TWNBa1ZIMDd4TXpydGpxSTBLY3VQcHBjbnE5M2k3bk5ySE4tbFhjbkpCV0NlVE05d1ZSQ3BMMmtCZTJ6TWI5R0VEcWN1UXhWV2UwUnl5R2YtdmNMa1ozUmlyYm5yV3pkbUtRb1lLcEJLOURwM3lzUQ?oc=5", "source_name": "Market source", "published_at": "2026-07-13T21:58:39+00:00", "published_display": "13 Jul 2026 21:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock reflects steady healthcare distribution role in a complex market", "summary": "Cencora Inc. plays a crucial role in the U.S. pharmaceutical supply chain as a large-scale distributor and services provider. The company's business model relies on high revenue volumes with thin margins, driven by efficient logistics, strong customer relationships, and expansion", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-reflects-steady-healthcare-distribution-role-in-a-complex/69759760", "source_name": "Ad Hoc News", "published_at": "2026-07-13T10:37:28", "published_display": "13 Jul 2026 10:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Stock Still Looks Undervalued On Cash Flow And Earnings", "summary": "Cencora (COR) stock appears undervalued based on its discounted cash flow (DCF) intrinsic value estimate and P/E ratio comparison. The DCF model suggests a 39.6% discount, while the P/E of 23.2x is below the healthcare sector average and a tailored benchmark. Investors should con", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/cencora-cor-stock-still-looks-undervalued-on-cash-flow-and-e/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-12T22:37:20", "published_display": "12 Jul 2026 22:37", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Cencora, Inc. Stocks", "summary": "This article provides a list of Exchange Traded Funds (ETFs) that hold shares of Cencora, Inc. The ETFs are sorted by their market value and include details such as weight in the fund, issuer, management style, expense ratio, assets under management (AUM), price, change percentag", "url": "https://www.tradingview.com/symbols/MIL-1COR/etfs/", "source_name": "TradingView", "published_at": "2026-07-10T19:07:29", "published_display": "10 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock trades steadily as healthcare distribution scale supports long-term growth", "summary": "Cencora Inc. plays a crucial role as a major U.S. healthcare distributor, focusing on pharmaceutical distribution, logistics, and related services, which are critical for connecting manufacturers, pharmacies, and healthcare providers. The company's stable demand in the healthcare", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-stock-trades-steadily-as-healthcare-distribution-scale-supports/69735878", "source_name": "Ad Hoc News", "published_at": "2026-07-10T07:32:00", "published_display": "10 Jul 2026 07:32", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. stock underperforms Thursday when compared to competitors", "summary": "Cencora Inc. (COR) shares dropped 2.30% to $302.46 on Thursday, despite a strong day for the broader stock market, which saw the S&P 500 Index and Dow Jones Industrial Average rise. This decline ended a six-day winning streak for the stock.", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-underperforms-thursday-when-compared-to-competitors-18244a68-7ade887d0eb8", "source_name": "MarketWatch", "published_at": "2026-07-09T20:46:00", "published_display": "09 Jul 2026 20:46", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardinal's Growth Momentum Looks Strong From Prescription Trends, Specialty Investments, and GLP-1s", "summary": "Cardinal Health, a major player in pharmaceutical distribution, is experiencing strong growth. This momentum is attributed to favorable prescription trends, strategic investments in specialty pharmaceuticals, and the rising impact of GLP-1 drugs. The company, alongside Cencora an", "url": "https://www.morningstar.com/company-reports/1487460-cardinals-growth-momentum-looks-strong-from-prescription-trends-specialty-investments-and-glp-1s", "source_name": "Morningstar", "published_at": "2026-07-09T20:08:36", "published_display": "09 Jul 2026 20:08", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pricing Headwinds and Industry Trends Cut Into Cencora's 2026 Sales, but Fundamentals Remain Strong", "summary": "Cencora, a key player in the pharmaceutical wholesale and distribution market, is facing pricing headwinds and industry trends that are projected to impact its 2026 sales figures. Despite a recent guidance cut and stock selloff, the company's fundamental business strategy and out", "url": "https://www.morningstar.com/company-reports/1487467-pricing-headwinds-and-industry-trends-cut-into-cencoras-2026-sales-but-fundamentals-remain-strong", "source_name": "Morningstar", "published_at": "2026-07-09T20:08:09", "published_display": "09 Jul 2026 20:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "McKesson's Oncology Leadership and Robust Free Cash Flow Underpin Strong Durable Fundamentals", "summary": "McKesson, a major pharmaceutical wholesaler, benefits from its leadership in oncology and strong free cash flow, contributing to its durable fundamentals. The company, along with Cardinal Health and Cencora, forms an oligopoly that distributes over 90% of the U.S. pharmaceutical ", "url": "https://www.morningstar.com/company-reports/1487466-mckessons-oncology-leadership-and-robust-free-cash-flow-underpin-strong-durable-fundamentals", "source_name": "Morningstar", "published_at": "2026-07-09T19:42:31", "published_display": "09 Jul 2026 19:42", "sentiment": "positive", "sentiment_pct": 67, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (NYSE:COR) Stock Forecast & Analyst Predictions", "summary": "Cencora (NYSE:COR) is projected to grow earnings by 5.9% and revenue by 5.6% annually, with EPS expected to increase by 9.2% per annum and a forecast return on equity of 53.8% in three years. Recent updates include increased EPS estimates for fiscal year 2026, though revenue outl", "url": "https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/future", "source_name": "Simply Wall Street", "published_at": "2026-07-09T07:07:27", "published_display": "09 Jul 2026 07:07", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. stock outperforms competitors on strong trading day", "summary": "Shares of Cencora Inc. (COR) rose 1.67% to $309.57 on Wednesday, marking its sixth consecutive day of gains. This performance occurred on a dismal trading day for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both declining. Cencora's stock consequen", "url": "https://www.marketwatch.com/data-news/cencora-inc-stock-outperforms-competitors-on-strong-trading-day-6f237afe-487d67085cdf?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-08T16:45:00", "published_display": "08 Jul 2026 16:45", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. focuses on pharmaceutical distribution scale as investors eye healthcare demand", "summary": "Cencora Inc. is a major U.S. pharmaceutical distributor, with its business model tied to prescription demand and healthcare utilization. The company specializes in distributing pharmaceuticals and offers supporting services, with a growing focus on specialty pharmaceuticals. Inve", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cencora-inc-focuses-on-pharmaceutical-distribution-scale-as-investors-eye/69720643", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T06:56:00", "published_display": "08 Jul 2026 06:56", "sentiment": "positive", "sentiment_pct": 70, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Adjusts Price Target on Cencora to $330 From $300", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-adjusts-price-target-131756525.html", "source_name": "MT Newswires", "published_at": "2026-07-07T13:17:56+00:00", "published_display": "07 Jul 2026 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. highlights its role in pharmaceutical distribution. Investors watch the company\u2019s evo", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPRXhzYUNmYWhtRjlDNmp5RHMyWnNyRFpaUkozZEQ0UVVaN1AtM1FUdWswYlIxN1J2Z0pQV1RHS1dTNGlyYnVVVk1aTFFhOWM3LWx4SUs5Z2JXSzEzV00tUGRVN3J4UVBQSFhFbWpla3pxTmthM3FIdHozb3hhSWMycl9FUFlRVnRrd1Y4UnJsZFBsMFBfaDF6Sk9hcDVxUUtXQndBOUc3RDJzUWpZbGxSeUU3MUx2MWJwTDA3aDV2bTEtWnhKbzRVVUF0Yw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-06T09:28:02+00:00", "published_display": "06 Jul 2026 09:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. focuses on healthcare distribution scale as investors assess long-term growth prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPbDZFSkkwY2tUNjFiSWNIdThZRUdWamhBMG8wNXFtUXVXck5HcHVNcTkwZE1jUXdMNVFDS2ZuQVZyY05LeGs3TVlHaGQ0SzVOVWwtd01FaDhGWU1nM0tmMmg2THlIQ2RqUkVwWFY2dlVqOVBCd01qWHhhMmlXYVVXYWlPNExkcW1SajM0V0ZCUUQyVkdhS3dEeEdpaHBENXRiQXVOZVpUeUM5dEdVRWhVZjJLc3BQNUNJUGJRc3ktVGJlY0ltRkNyaHJOQQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-03T13:17:43+00:00", "published_display": "03 Jul 2026 13:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cencora-announces-date-time-third-203000029.html", "source_name": "Business Wire", "published_at": "2026-07-01T20:30:00+00:00", "published_display": "01 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora lines up Aug. 5 earnings call before NYSE opens", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPY2xlRlVmRDMxbFZ2cXNUb2xkWndQcEJiRjJFSC1XQkkxRVJscmxvN0FBNFhqUDFrd2IwVHFFX0hyZi1PUzVCY19PcjRuclF6TE9IMlJESWNXdzNwYTZ2UW9telZvazc0RkxNRFVGeUs2U2lHME5TTVNNTll1NDVSM1luaDBMZEhJV2lfbi1qLUhRVDhRUkxWaDZfNW1ORTBWYmhNYnlKODFhTm1qOThYSkF2akdxUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cencora-pick-week-smart-insider-134146124.html", "source_name": "MT Newswires", "published_at": "2026-06-30T13:41:46+00:00", "published_display": "30 Jun 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora reports steady business model, shares anchored in US healthcare distribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONFg0Tm1WdnZncTI3SXp4ckFkUVk3NkVwNVNDWHRjandXQUp5VUJIZHN1WnFLM0xRZ1ozeXpEcWRQRWR1RE9PZHIzMWlJQ0hqOVltWDRXUlZhVUtBYmRCQVQ4Qk5WcHNTM2xrS0d4YmlyZy1TdHRCTVh4WmoxdVYzNnhzZDBYNXZIemxmZ0lOQ0d5MzItQUpaRmVBVUE4YUNuVTF3Tnh2OXYtWFVzTnJLem5Mb1RpMHlBREMtQUlGLXFyT3VGWFBreg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-30T10:13:12+00:00", "published_display": "30 Jun 2026 10:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNenppZ3JZbDRIVUw3Ukl4dVg2bE91WGh5WkxjYkRNNW9vNWdfZ01TMlJsdHhWRUNyU0E1NjAyUXRBcGM0TWZib2dKOFQ1NEY1Y29zUFc0ZlYydTNoeVRVVXpIc0RWbDJzSkJYRzNuS3FlazJJeEx1M29kT1JXb2w1d19Wbkt4TnVCNlBkNmpBVjNEeVZRQU5LUUdHQnR5SG8?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNbmVndmI3eTFsUDNHSjhGYTVSWG1hWDI4SE5EZUFnYXdMUVdsYmxUY01SRk5iX1IwQkF6WGFqOWVyV042OGNWczRrei1MUHc3cUxNSkZzaGVOQ3NtVXVpY2ZHdWRRLU9CZ05VQlFQaW5iNXhyZ3o3bzZaX3NlNTRoZlhwZEs3ZkwzTFp1ZjhMWEdDcFFsY3d4ZUdva0NPdHVV?oc=5", "source_name": "Market source", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) director adds 4,000 shares in open-market stock purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOb1pwaVVDUVJoSldvUnlIYWMxWXUxWTZwQkRldHA1Qkpqd01MWWtULWlIbmxjTFJrTzFCbVZTdzhjd1YzOE1jWDg0b1BGWjNqcGg0SzRXZlR0NWNocmVkUThuVThkQVAwMUE0cjBka2hTWGJqUWlCVHIyYTJVM3JPeWw2NDdjUlBvQ3ItUHQ0bzNYRmVId3BQNlJvc29DTFUxeTRRb2hvcw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Stock - Saturday spotlight on the business model behind the drug distributor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOY1dpekNMTUJzRmlMOW1MSUFTcHRTYlJPVG5lb3A2OEpsOVVBT2ZFRldZTkhnZTU3U2pVVjA1V3BwYXIzdWlmaHdjX29pZzg3VXJZWG1nSGN6TjVUeENKUFpHeWE1dVV6TEpvVWJFd1pzWkJoSVJrbU15OUJkalgtcjRSdkdKNExUNE1tRE1tMHNTSVJ1aUxMNHJzd3ZxeFRNLTU2ZUxaQWJwWVBHVE53MlhWNDhSWHhrLTJfVjlLUjBySXhDUTVMYw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T08:32:54+00:00", "published_display": "20 Jun 2026 08:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. Stock (US15135B1017): Valuation metrics in focus after steady share price climb", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPa0RfOEJXbEw0UTh6SFRwdmloWmQzam5nTjRYVUJ6ODRweGhEU3FKdWhDNGplWG03dEp1Y0taNVRLOFkwSXJRZmFpN0JkVlh5YWJ6M0JTZWdrMzFISDFNVzZuOVhKTUlzRnBwREN4eU5nekJ2MTNtbXktREcyT2hVTEhRTlRXcmRDdU9yaVlWLUEtVHJLZWFfOWpNUHpLMTdLdHl1MDR5VjZfd0QwSlZmeWNxaWY3NEtBMW5lVkVZSFg3QUV6d1JwUA?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Cencora Stock Underperforming the Nasdaq?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOUkFZWlF6S2dzbS1EOVotci1TTHpTYzZWRWNCRHI0aGFSQl9jWnNCLWgyckMtV2dVd3pZajhWVThhOEdtODc4NkZ0RkJGWWRZUFBXdUU1ODk3S2NKLThOV2JLMjlEcTRuQkpRWGFySXpGbllFSXExQjBkaG5lei1yTlIxa2VlMGl5U2FwVjJmcXVzSlJNQ2t1LTlUV1luVE1xdk5J?oc=5", "source_name": "Market source", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora-Kite Agreement Signals CGT Commercialization Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPMVMwcHc2RG44T1hXYVVCMVJZMFJBbndROXhNWjZ6SWlXSXQ2SW4zWUpjeEotRFZ3d1hPU1ZldlpDM0I4dkxySjJpeDQ4Q2xIUk41elpXUzhETjhvY085QTZxaElZazhrUXpVV0lpVXhTYlJkLVJSU2hpRDl0eG1TZ3l1S3ZhTURweFhpeVoxN0hnOTNNTWlTRkZVUjY?oc=5", "source_name": "Pharmaceutical Commerce", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Spends US$1.1m Buying More Shares In Cencora", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora stock (US15135B1017): transformation story after name change and solid earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxORHFwY0p6REdmazhaNjRkdmJDZGhfdlM0ZF9VdmpoQ01aUWFaSUlyYmdZNG8tSjJvVm83bFIyYXRGbFY2dVBWX1NOYVM5TmlwckZQVXRDN05VejJTX3lPZGtCMThqaDdjeVNGYk0xQmYzRjViQWpRcGhWaUREYzZQWG9ZQVhrNkxZOTdoQ3lMbVlXSlVfSXo5TzFVUHFqUkN2bWpJOHZLeEdhUEVGZjRQZzFwRTJRRXl1R2trdkR3TzVvWUtYYU5J?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wells Fargo Maintains Overweight Rating on Cencora (COR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNeVQydkZFUlNGd2ZEa1h2UkN0SEpjcUtmR0J6SkJZa3plS1hvaUs1cW1OVUdfdWVPQWtCYVlDeXFvMzZGSDF6ZEUzT3dIQkdvUmFJY1FPMjJRWkxyQXdKSFRWZGt0OF9pS3lQM0l5ZnVlaFpCOTh2THlQVmdrVzRZaTdaQUx1d0JyZkhYbm1DOFhCVFItRVBpYWJsZ3FHWHRheUVxUjRZMA?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (NYSE:COR) Could Be A Buy For Its Upcoming Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPVk9vclQ5VElSbkI4ZTJHbks2VzJaVXlmbS1XNWNkNE1TdVo1ZkRkaU5EcDMzQ3NiSWdPR3ZGV2dfazZFWXhaY1NMX2Y5bTlQMTc1bmV5aUVyVEFIWEJsOVcydno1bTdiMFRoWnU1Ti05eDN3WVNpZ2xuYktCc2hFRmVRLVJvT0VvZHNwRVdaTUxJaFFBOUh0WVFMMC1pSXZWS0Zta2pLbmhaRmljLTNycl95cV9QeEpnVkV3MF9Udk_SAcYBQVVfeXFMTkRWRTZTWm5fMFdETDNqU1ZxQzhKUWRURGlyRGgtS1lIQVVMZFRHeWZCbUlKN09JSmViNkR0YmVxUTFrZEJkcTZtS0wxaDdwM0N0YWxKM3R5OXFMc1JPd2tJMi0zd3c4UnpkNlhST0VQeHc1V2pmU2hTNkpsRUpqQjVfY2VfSERBNE5hWnhHWWxaWDNaRmg2cWRLbHhsbUItTElraVFfcUNJWmlfdDhIdHZkRlpPMDFiM3c1VVAxek02d2laQnl3?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Q2 2026 EPS Surge Tests Bullish Earnings Growth Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Misses Q2 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPYVppeHphSXQ4OWFObkhWNEdKOHFQUmRPRzhMZm0ySWFYQmYxYUhzSlNHdGZxdWtGcF9sS0xnUnYzNnZXejZOSVJ6QWpnMk4yRkN6LU5ZZUFnVXFlV3o1WjJDbkZ6QkJ5c2ZYeENKY0EtbUNYTUlqNTVPMFpYMm04b0h0ZmI1c2VKVExYU3NfU2s4MEktM0lxV1RFZw?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNNWJKODBSQmlMaGtXQVVBbnNxUzJldmEyWEdnblZtUWdxVkpuTGZ1ajd2Z2ZHWG9JTVZYYXVwTWJZb2tfcmtmRk0wS1hxSjBYNlJjQTZ6VkJuc01JUFVEOG0zYWNSbEJqZkk2VDJMa3h3WEhZbVQ2ZmtLQldYQjNCZTVZUm1IREQyOTRaWnhrM181Qkd6LUJqeGlR?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora will post quarterly results before the market opens May 6", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOSWRtUXZqaFFsYkI5YjdSYTh0bmVFeTRFTWx2OEpjbUNSaUNnVklrdF93WTV0YW5jd3NnSjRrTmRrUllyY0JSUDgxT0VzLTBfTXBTakphYkxCMVh6QkcxYmNmUTNYZlBPMW5RT2g1R1dFTFpveXRLZm9kNk1zbGt5OU9QemFjbWp0X1EyQkw3SFNlT29nYVlmVm5oMEs4NmhIekxMVVoyUmk5QzQ4Q3BBM1JCckdBaGM?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPNVpMa3RjQ2NZdmVFZGxMMTUyaXZsU09yVkFiYnhNenRRc0tnVnphRHd2bVlEVkFqeVBsT0FhX0dFSmR4M0xIUDR5X3FVMUpmQ283R04tLW01TVJLZzlLdm9UVXpPTlVrdUFQZTd3dTcyeTVwUno0MUxWb2FLNVMwdG1vNXVZRi1wR0VoLUNSYXVUNGhudW80QmttRDk1QQ?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora's $1.1B eye-care deal adds EyeSouth retina doctors", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOUDk4dmNRSXh0ajMxbU5CVXoxai01cC1vTUxha25yZEIyNzhGWGNETWp1QU9XZWwzMVdYWTlWdUZPMHlxYS1YcFNMMjRVc0JieWx3SWRCbUlLTmtQcHJSeGQ3MnRyR3RBeXJsNjJlZFJkN3pwdko4eWFyUjVjY0h3ejl3SU1oX2VGOEJXaXN3di1ManhtRjhxcDNPQi1VamZCR2o2YVU2VzFZVW1nbkpHaTJ0U0lJSmh1SVZTeWZn?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora (COR) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBKZ0JjM2d5Y09yMEFfdEs3U0lYRmtBMlJBTUxGWm5PMW5zOWhGbnVJR01XeWM5RS15QUhuSmY4dGQ3enF0UVBkajV2blJUY0Z0V21xM0J4Z2txM1Z1QnRGQ3Q1LUxRQWhIMUZudFlGZ3hQWXlMekxramVUQkZhb1k?oc=5", "source_name": "Market source", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora Inc. (COR) Stock Price Today & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE15anVpYURlbEVpSVhpX1JLSms5b0l1OGZQVEoxcXRtZ1pHY0ZqWkVXNk53YXN1eVk1UzNFallmMW1veEJtd1BtS1JzOFRrWlhlRUdBRTZR?oc=5", "source_name": "Gotrade", "published_at": "2026-02-02T14:40:24+00:00", "published_display": "02 Feb 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-09T07:00:00+00:00", "published_display": "09 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 108, "total_relevant": 52, "sentiment_summary": {"positive": 18, "negative": 5, "neutral": 29, "score": 55, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 16.6, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 7.15, "count": 13}, {"event": "macro", "label": "Macro sensitivity", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.45, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.9, "count": 1}], "positive_events": 18, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 303.44, "latest_week": "2026-07-10", "one_week_move": 2.3, "four_week_move": 7.7, "twelve_week_move": -7.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.207696, "market_dynamics_buy_signal": false, "relative_strength": -14.224958, "fair_value_gap": 17.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.6585, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.3% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad Hoc News", "count": 9}, {"label": "Market source", "count": 9}, {"label": "TradingView", "count": 7}, {"label": "MarketWatch", "count": 4}, {"label": "Simply Wall Street", "count": 4}, {"label": "Stock Titan", "count": 4}, {"label": "simplywall.st", "count": 4}, {"label": "Morningstar", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 13}, {"label": "Macro sensitivity", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "7", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.3% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Cencora Inc. stock underperforms Wednesday when compared to competitors"}], "updated_at": "2026-07-16T05:41:28.478626+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}